478 related articles for article (PubMed ID: 34515137)
1. The Role of Innate Immune Cells in Nonalcoholic Fatty Liver Disease.
Nati M; Chung KJ; Chavakis T
J Innate Immun; 2022; 14(1):31-41. PubMed ID: 34515137
[TBL] [Abstract][Full Text] [Related]
2. [Macrophage heterogeneity role in NAFLD and NASH disease progression].
Yang T; Wang X; Jiang LF; Li J
Zhonghua Gan Zang Bing Za Zhi; 2023 Jul; 31(7):770-775. PubMed ID: 37580264
[TBL] [Abstract][Full Text] [Related]
3. The complex function of macrophages and their subpopulations in metabolic injury associated fatty liver disease.
Subramanian P; Chavakis T
J Physiol; 2023 Apr; 601(7):1159-1171. PubMed ID: 36825510
[TBL] [Abstract][Full Text] [Related]
4. Dietary Lipids Differentially Shape Nonalcoholic Steatohepatitis Progression and the Transcriptome of Kupffer Cells and Infiltrating Macrophages.
McGettigan B; McMahan R; Orlicky D; Burchill M; Danhorn T; Francis P; Cheng LL; Golden-Mason L; Jakubzick CV; Rosen HR
Hepatology; 2019 Jul; 70(1):67-83. PubMed ID: 30516830
[TBL] [Abstract][Full Text] [Related]
5. The role of immune cells in metabolism-related liver inflammation and development of non-alcoholic steatohepatitis (NASH).
Nati M; Haddad D; Birkenfeld AL; Koch CA; Chavakis T; Chatzigeorgiou A
Rev Endocr Metab Disord; 2016 Mar; 17(1):29-39. PubMed ID: 26847547
[TBL] [Abstract][Full Text] [Related]
6. Pathophysiology of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis.
Manne V; Handa P; Kowdley KV
Clin Liver Dis; 2018 Feb; 22(1):23-37. PubMed ID: 29128059
[TBL] [Abstract][Full Text] [Related]
7. Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments.
Kitade H; Chen G; Ni Y; Ota T
Nutrients; 2017 Apr; 9(4):. PubMed ID: 28420094
[TBL] [Abstract][Full Text] [Related]
8. Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-α production.
Tosello-Trampont AC; Landes SG; Nguyen V; Novobrantseva TI; Hahn YS
J Biol Chem; 2012 Nov; 287(48):40161-72. PubMed ID: 23066023
[TBL] [Abstract][Full Text] [Related]
9. The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Kazankov K; Jørgensen SMD; Thomsen KL; Møller HJ; Vilstrup H; George J; Schuppan D; Grønbæk H
Nat Rev Gastroenterol Hepatol; 2019 Mar; 16(3):145-159. PubMed ID: 30482910
[TBL] [Abstract][Full Text] [Related]
10. Macrophage functional diversity in NAFLD - more than inflammation.
Barreby E; Chen P; Aouadi M
Nat Rev Endocrinol; 2022 Aug; 18(8):461-472. PubMed ID: 35534573
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis.
Krenkel O; Puengel T; Govaere O; Abdallah AT; Mossanen JC; Kohlhepp M; Liepelt A; Lefebvre E; Luedde T; Hellerbrand C; Weiskirchen R; Longerich T; Costa IG; Anstee QM; Trautwein C; Tacke F
Hepatology; 2018 Apr; 67(4):1270-1283. PubMed ID: 28940700
[TBL] [Abstract][Full Text] [Related]
12. Roles of Hepatic Innate and Innate-Like Lymphocytes in Nonalcoholic Steatohepatitis.
Chen Y; Tian Z
Front Immunol; 2020; 11():1500. PubMed ID: 32765518
[TBL] [Abstract][Full Text] [Related]
13. Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism.
Lefere S; Tacke F
JHEP Rep; 2019 May; 1(1):30-43. PubMed ID: 32149275
[TBL] [Abstract][Full Text] [Related]
14. Effect of Microbiome on Non-Alcoholic Fatty Liver Disease and the Role of Probiotics, Prebiotics, and Biogenics.
Nagashimada M; Honda M
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360773
[TBL] [Abstract][Full Text] [Related]
15. Treating inflammation to combat non-alcoholic fatty liver disease.
Wiering L; Tacke F
J Endocrinol; 2023 Jan; 256(1):. PubMed ID: 36259984
[TBL] [Abstract][Full Text] [Related]
16. Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.
Suppli MP; Rigbolt KTG; Veidal SS; Heebøll S; Eriksen PL; Demant M; Bagger JI; Nielsen JC; Oró D; Thrane SW; Lund A; Strandberg C; Kønig MJ; Vilsbøll T; Vrang N; Thomsen KL; Grønbæk H; Jelsing J; Hansen HH; Knop FK
Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G462-G472. PubMed ID: 30653341
[TBL] [Abstract][Full Text] [Related]
17. The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Cha JY; Kim DH; Chun KH
Lab Anim Res; 2018 Dec; 34(4):133-139. PubMed ID: 30671098
[TBL] [Abstract][Full Text] [Related]
18. The Multifaceted Roles of Macrophages in NAFLD Pathogenesis.
Vonderlin J; Chavakis T; Sieweke M; Tacke F
Cell Mol Gastroenterol Hepatol; 2023; 15(6):1311-1324. PubMed ID: 36907380
[TBL] [Abstract][Full Text] [Related]
19. Myeloid-specific IRE1alpha deletion reduces tumour development in a diabetic, non-alcoholic steatohepatitis-induced hepatocellular carcinoma mouse model.
Van Campenhout S; Tilleman L; Lefere S; Vandierendonck A; Raevens S; Verhelst X; Geerts A; Van Nieuwerburgh F; Van Vlierberghe H; Devisscher L
Metabolism; 2020 Jun; 107():154220. PubMed ID: 32243868
[TBL] [Abstract][Full Text] [Related]
20. Hepatic inflammatory responses in liver fibrosis.
Hammerich L; Tacke F
Nat Rev Gastroenterol Hepatol; 2023 Oct; 20(10):633-646. PubMed ID: 37400694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
